Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has an overall 5-year survival rate of just 12.5% and thus is among the leading causes of cancer deaths. When detected at early stages, PDAC survival rates improve substantially. Testing high-risk patients can increase early-stage cancer detection;...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinestrosa, Juan Pablo, Sears, Rosalie C., Dhani, Harmeet, Lewis, Jean M., Schroeder, Gregor, Balcer, Heath I., Keith, Dove, Sheppard, Brett C., Kurzrock, Razelle, Billings, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587093/
https://www.ncbi.nlm.nih.gov/pubmed/37857666
http://dx.doi.org/10.1038/s43856-023-00351-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587093/
https://www.ncbi.nlm.nih.gov/pubmed/37857666
http://dx.doi.org/10.1038/s43856-023-00351-4

Ejemplares similares